EPISODE · Sep 21, 2016 · 17 MIN
Icahn v. Ackman
from Rangeley Capital Podcast · host Rangeley Capital Podcast
Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss the ongoing Bill Ackman / Carl Icahn feud over Herbalife (HLF). Then, they discuss the rational behind the massive premiums Allergan (AGN) paid for Tobira (TBRA) and Vitae (VTAE).
Embed this episode
Ready to play
Icahn v. Ackman
0:00
17:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Rangeley Capital Podcast?
This episode is 17 minutes long.
When was this Rangeley Capital Podcast episode published?
This episode was published on September 21, 2016.
Can I download this Rangeley Capital Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!